These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Polo-like kinase-1 controls Aurora A destruction by activating APC/C-Cdh1. van Leuken R; Clijsters L; van Zon W; Lim D; Yao X; Wolthuis RM; Yaffe MB; Medema RH; van Vugt MA PLoS One; 2009; 4(4):e5282. PubMed ID: 19390576 [TBL] [Abstract][Full Text] [Related]
3. Cdc14B and APC/C tackle DNA damage. De Wulf P; Visintin R Cell; 2008 Jul; 134(2):210-2. PubMed ID: 18662536 [TBL] [Abstract][Full Text] [Related]
4. USP7 counteracts SCFbetaTrCP- but not APCCdh1-mediated proteolysis of Claspin. Faustrup H; Bekker-Jensen S; Bartek J; Lukas J; Mailand N J Cell Biol; 2009 Jan; 184(1):13-9. PubMed ID: 19124652 [TBL] [Abstract][Full Text] [Related]
5. Polo-like kinase 1 activated by the hepatitis B virus X protein attenuates both the DNA damage checkpoint and DNA repair resulting in partial polyploidy. Studach L; Wang WH; Weber G; Tang J; Hullinger RL; Malbrue R; Liu X; Andrisani O J Biol Chem; 2010 Sep; 285(39):30282-93. PubMed ID: 20624918 [TBL] [Abstract][Full Text] [Related]
6. Dun1, a Chk2-related kinase, is the central regulator of securin-separase dynamics during DNA damage signaling. Yam CQX; Chia DB; Shi I; Lim HH; Surana U Nucleic Acids Res; 2020 Jun; 48(11):6092-6107. PubMed ID: 32402080 [TBL] [Abstract][Full Text] [Related]
7. Activation of Cdh1-dependent APC is required for G1 cell cycle arrest and DNA damage-induced G2 checkpoint in vertebrate cells. Sudo T; Ota Y; Kotani S; Nakao M; Takami Y; Takeda S; Saya H EMBO J; 2001 Nov; 20(22):6499-508. PubMed ID: 11707420 [TBL] [Abstract][Full Text] [Related]
8. Mitotic DNA damage response: Polo-like kinase-1 is dephosphorylated through ATM-Chk1 pathway. Lee HJ; Hwang HI; Jang YJ Cell Cycle; 2010 Jun; 9(12):2389-98. PubMed ID: 20581453 [TBL] [Abstract][Full Text] [Related]
9. p53- and p21-dependent premature APC/C-Cdh1 activation in G2 is part of the long-term response to genotoxic stress. Wiebusch L; Hagemeier C Oncogene; 2010 Jun; 29(24):3477-89. PubMed ID: 20383190 [TBL] [Abstract][Full Text] [Related]
10. Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis. Eckerdt F; Strebhardt K Cancer Res; 2006 Jul; 66(14):6895-8. PubMed ID: 16849530 [TBL] [Abstract][Full Text] [Related]
11. The ubiquitin ligase APC(Cdh1) is required to maintain genome integrity in primary human cells. Engelbert D; Schnerch D; Baumgarten A; Wäsch R Oncogene; 2008 Feb; 27(7):907-17. PubMed ID: 17700535 [TBL] [Abstract][Full Text] [Related]
12. Polo-like kinase-1 controls proteasome-dependent degradation of Claspin during checkpoint recovery. Mamely I; van Vugt MA; Smits VA; Semple JI; Lemmens B; Perrakis A; Medema RH; Freire R Curr Biol; 2006 Oct; 16(19):1950-5. PubMed ID: 16934469 [TBL] [Abstract][Full Text] [Related]
14. Expression of constitutively active CDK1 stabilizes APC-Cdh1 substrates and potentiates premature spindle assembly and checkpoint function in G1 cells. Ma Y; Yuan X; Wyatt WR; Pomerening JR PLoS One; 2012; 7(3):e33835. PubMed ID: 22479455 [TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus 16 E7 oncoprotein attenuates DNA damage checkpoint control by increasing the proteolytic turnover of claspin. Spardy N; Covella K; Cha E; Hoskins EE; Wells SI; Duensing A; Duensing S Cancer Res; 2009 Sep; 69(17):7022-9. PubMed ID: 19706760 [TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of Plk1 at S137 and T210 is inhibited in response to DNA damage. Tsvetkov L; Stern DF Cell Cycle; 2005 Jan; 4(1):166-71. PubMed ID: 15611664 [TBL] [Abstract][Full Text] [Related]
17. Cyclin A2-cyclin-dependent kinase 2 cooperates with the PLK1-SCFbeta-TrCP1-EMI1-anaphase-promoting complex/cyclosome axis to promote genome reduplication in the absence of mitosis. Ma HT; Tsang YH; Marxer M; Poon RY Mol Cell Biol; 2009 Dec; 29(24):6500-14. PubMed ID: 19822658 [TBL] [Abstract][Full Text] [Related]
18. APC/C(Cdh1) targets brain-specific kinase 2 (BRSK2) for degradation via the ubiquitin-proteasome pathway. Li R; Wan B; Zhou J; Wang Y; Luo T; Gu X; Chen F; Yu L PLoS One; 2012; 7(9):e45932. PubMed ID: 23029325 [TBL] [Abstract][Full Text] [Related]